ClinConnect ClinConnect Logo
Search / Trial NCT06463756

AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma

Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jun 17, 2024

Trial Information

Current as of September 10, 2025

Recruiting

Keywords

Radiomics Deep Learning

ClinConnect Summary

This clinical trial is studying how artificial intelligence (AI) can help doctors predict whether laryngeal cancer has invaded the thyroid cartilage, which is an important structure in the neck. By using CT scans, the researchers aim to create a model that provides more accurate information before surgery, helping doctors make better treatment decisions. They are also looking at how well this model can predict patient survival outcomes.

To participate in the trial, individuals should be between 65 and 84 years old and need to have a confirmed diagnosis of laryngeal squamous cell carcinoma, either through surgery or a biopsy. They must also have had a CT scan within two weeks before their surgery. However, patients who have received chemotherapy or radiation therapy before the surgery, those with certain issues in their CT images, or those whose cancer has returned will not be eligible. If you join this study, you can expect to contribute to important research that could improve the way laryngeal cancer is diagnosed and treated in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Availability of complete clinical data
  • 2. Surgery-proven or biopsy-proven diagnosis of laryngeal squamous cell carcinoma
  • 3. CT examination performed within 2 weeks before surgery
  • Exclusion Criteria:
  • 1. Patients who received preoperative chemotherapy or radiation therapy
  • 2. CT images with significant artifacts
  • 3. Patients with tumor recurrence

About First Affiliated Hospital Of Chongqing Medical University

The First Affiliated Hospital of Chongqing Medical University is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, the hospital is committed to conducting high-quality, ethically-driven studies that contribute to the understanding and treatment of various medical conditions. With a robust infrastructure and a team of experienced researchers and healthcare professionals, the institution fosters collaboration across disciplines to enhance patient care and improve health outcomes. Its strategic focus on translational medicine underscores the hospital's role in bridging the gap between laboratory discoveries and clinical applications, ultimately benefiting patients and the broader medical community.

Locations

Chongqing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported